Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.3110
+0.0168 (5.71%)
Nov 17, 2026, 9:32 AM EST - Market open

Bone Biologics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-3.01-3.23-4.22-9.43-3.67-1.1
Net Income
-2.84-3.11-7.32-8.95-1.48-1.61
Earnings Per Share
-1.24-2.65-28.96-204.05--
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.095.333.333.037.546.68
Total Debt
------
Net Cash (Debt)
6.095.333.333.037.546.68
Net Cash Growth
0.65%60.42%9.87%-59.85%12.93%-
Net Cash Per Share
2.664.5413.1469.01--

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.57-2.69-4.12-9.56-3.57-1.23
Capital Expenditures
------
Free Cash Flow
-2.57-2.69-4.12-9.56-3.57-1.23
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.